Document Detail


Treatment of urinary incontinence in cystic fibrosis.
MedLine Citation:
PMID:  15463869     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Urinary incontinence (UI) is a newly recognised problem in cystic fibrosis. Whilst prevalence is well documented, there are no reports of assessment and treatment of the problem. METHODS: A previous study reports the prevalence of UI in women with CF to be 51/75 (68%). Nineteen women subsequently requested help for the problem and were referred to a physiotherapist specialising in women's health. A digital assessment was performed to measure pelvic floor muscle strength and endurance. An individualised programme of pelvic floor muscle exercises (PFME) was taught based on the assessment. A questionnaire addressed issues of assessment and treatment. RESULTS: 12 women were assessed. The median (range) age, FEV1% predicted and BMI were 20.9 (19.3-46.1) years, 45.9 (14.8-82.7) and 20.5 (16.1-26.0), respectively. The median strength of the pelvic floor muscle was moderate (Oxford Scale grade 3) with a hold time (endurance) of 5 s. At reassessment (median time 13.1 weeks), there was an improvement in endurance (P = 0.04), with no change in strength. This was supported by a subjective improvement in symptoms. Patients found the exercises were difficult to perform, difficult to fit into their treatment programme and adherence was poor. CONCLUSIONS: PFME are effective at improving endurance and reducing leakage over the short-term. Women are reluctant to be assessed and the CF team should provide support and encouragement with treatment. Long-term outcome and the mechanisms of UI in this group of patients need further evaluation.
Authors:
R J McVean; A Orr; A K Webb; A Bradbury; L Kay; E Philips; M E Dodd
Related Documents :
17043739 - Comparison of transperineal and transabdominal ultrasound in the assessment of voluntar...
7802389 - Sheep as maintenance host for leptospira interrogans serovar hardjo subtype hardjobovis.
12271229 - Postnatal pelvic floor screening clinics: a pilot study.
23123199 - Neurobiological markers of exercise-related brain plasticity in older adults.
6860319 - Protein turnover and physical fitness in man.
23647569 - Impaired vascular katp function attenuates exercise capacity in obese zucker rats.
20559999 - Exercise in hypertrophic cardiomyopathy.
11416449 - The effects of aging and endurance exercise on cardiovascular performance in healthy el...
16314239 - Systematic diagnostic approach to proximal-without-distal claudication in a vascular po...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society     Volume:  2     ISSN:  1569-1993     ISO Abbreviation:  J. Cyst. Fibros.     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2004-10-06     Completed Date:  2004-11-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  101128966     Medline TA:  J Cyst Fibros     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  171-6     Citation Subset:  IM    
Copyright Information:
Copyright 2003 European Cystic Fibrosis Society
Affiliation:
Manchester Adult Cystic Fibrosis Centre, South Manchester University Hospitals NHS Trust, Southmoor Road, Manchester M23 9LT, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Cohort Studies
Cystic Fibrosis / complications*,  diagnosis
Exercise Therapy*
Female
Follow-Up Studies
Humans
Middle Aged
Pelvic Floor
Prevalence
Questionnaires
Risk Assessment
Severity of Illness Index
Statistics, Nonparametric
Treatment Outcome
Urinary Incontinence / epidemiology,  etiology*,  therapy*
Urinary Incontinence, Stress / etiology,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of exercise and nutrition status on bone mineral density in cystic fibrosis.
Next Document:  Effects of creatine supplementation in cystic fibrosis: results of a pilot study.